Spotlight on Myeloproliferative Neoplasms

CME

Educational Objectives

  1. Improve the understanding of contemporary treatment of myeloproliferative neoplasms (MPNs)
  2. Recognize the key molecular drivers of MPNs as well as appropriate testing for response and resistance to therapy 
  3. Gain insight into novel experimental therapy options for MPNs 

Event Information

Date & Time(s)
Sunday, October 19, 2014 (All day)
Sponsor(s)

Memorial Sloan Kettering Cancer Center

Speaker(s)
Audience

This course is directed towards physicians and allied health professionals who care for patients with myeloproliferative neoplasms including:

  • Chronic Myeloid Leukemia
  • Polycythemia Vera
  • Myelofibrosis
  • Essential Thrombocythemia
  • Chronic Eosinophilic Disorders
  • Systemic Mastocytosis
Credit

Memorial Sloan Kettering Cancer Center designates this educational activity for a maximum of 6.0 AMA PRA Category 1 Credits. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Location Information

Memorial Sloan Kettering Cancer Center
Zuckerman Research Center
Auditorium
417 East 68th Street
Between First and York Avenues
New York, NY 10065

Contact Information

Phone
646-227-2025
Fax
212-557-0773

Registration Information

Registration Details

Register online. Syllabus will be provided in electronic format only.

Payment Information
Registrant's Information

Examples: Dr. Robert Smith, Robert A. Smith, M.D., Bob Smith

Mailing Address
Contact Information
Professional Information
Additional Information
Your Suggestions
Billing Information
Credit Card Information